New Stanford Medicine research found that a compound called d-limonene has the potential to help head and neck cancer patients who suffer from dry mouth.
A new exhibit at Stanford's Cantor Arts Center draws on the themes of technology, medicine and ethics raised in Mary Shelley's novel, Frankenstein.
Dekel Gelbman, CEO of FDNA, speaks on the role of artificial intelligence in health care, and how he sees AI contributing to genetic diagnostic in particular.
A new gene-editing technology enables scientists to make thousands of edits at once and track them with specific barcodes.
Regulatory reform could reduce the bloated documentation requirements facing American physicians and help to reduce rising levels of burnout.
An app-based health training and triaging program spearheaded by Stanford's Ayesha Khan is now in use in India, and has led to the creation of village-based health workers.
Researchers and ePatients at Stanford Medicine X | Ed talk about the benefits and risks of discussing personal health issues online.
Dean Lloyd Minor from Stanford and Bon Ku from Thomas Jefferson University weigh in on forces transforming medical care.
In a proof-of-principle study, Stanford scientists and colleagues used the CRISPR/Cas9 system to modify genes in coral, suggesting that the tool could one day aid conservation efforts.
Stanford Medicine will unite leading minds in patient care, technology, design thinking and public policy to help shape the future of electronic health records and at the EHR National Symposium on June 4.
A Stanford symposium asks: In the midst of technological progress, how do doctors retain the human touch with patients and ensure that new developments enhance, rather than impede, their profession?
Stanford researchers develop a new way to track the growth of diverse tumor types, using gene editing and DNA barcoding.
Pediatric cardiologist and biomedical innovator Bronwyn Harris talks about the challenge of translating data into better outcomes for kids with chronic diseases.
In 1968, the first successful adult heart transplant took place at Stanford. Here's what has happened since then.
Serial health technology entrepreneur Josh Makower described his work developing devices that make medical procedures better for patients by seeking to "help the body do what it would want to do on its own."
A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
